Advertisement

Pembrolizumab

C3 glomerulonephritis: case report

    • 13 Accesses

    This is a preview of subscription content, log in to check access.

    Access options

    Buy single article

    Instant unlimited access to the full article PDF.

    US$ 49.95

    Price includes VAT for USA

    Reference

    1. Ville S, et al. C3 glomerulonephritis in a patient treated with anti-PD-1 antibody. European Journal of Cancer 125: 46-48, Jan 2020. Available from: URL: https://doi.org/10.1016/j.ejca.2019.11.011

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Verify currency and authenticity via CrossMark

    Cite this article

    Pembrolizumab. Reactions Weekly 1786, 134 (2020) doi:10.1007/s40278-020-73608-4

    Download citation